Bernstein Maintains Market Perform on Fresenius Medical Care, Raises Price Target to $25.8

Benzinga Newsdesk www.benzinga.com Positive 83.3%

Neg 0% Neu 0% Pos 83.3%

Bernstein analyst Lisa Clive maintains Fresenius Medical Care (NYSE:FMS) with a Market Perform and raises the price target from $25.5 to $25.8.